When You Can't Get Afrezza, These Are Your Options

Afrezza changed the game for people who want mealtime insulin without injections. But what happens when you can't fill your prescription? Maybe your pharmacy doesn't stock it, your insurance denied the prior authorization, or the cost is too high even with savings programs.

Whatever the reason, you still need to manage your blood sugar at meals. Here are the alternatives worth discussing with your doctor.

What Is Afrezza and How Does It Work?

Afrezza is an ultra rapid-acting inhaled insulin made by MannKind Corporation. Approved by the FDA in 2014, it's the only insulin you breathe in rather than inject. It uses Technosphere technology — insulin adsorbed onto tiny microparticles that dissolve rapidly in your lungs — to deliver insulin into your bloodstream in about 12 minutes.

It's prescribed for adults with type 1 diabetes (alongside long-acting insulin) and type 2 diabetes. It comes in single-use cartridges of 4, 8, or 12 units, and its effects wear off in about 1.5 to 3 hours — faster than any injectable rapid-acting insulin.

For a complete overview, see our guide: What Is Afrezza? Uses, Dosage, and What You Need to Know.

How Does Afrezza Compare to Other Mealtime Insulins?

What makes Afrezza unique is its speed and delivery method. It's the only inhaled insulin available, and it acts faster than any injectable insulin on the market. Here's how it stacks up:

• Onset: ~12 minutes (vs. 15-30 minutes for rapid-acting injectables)
• Peak: ~35-55 minutes (vs. 1-2 hours for injectables)
• Duration: ~1.5-3 hours (vs. 3-5 hours for injectables)
• Delivery: Inhaled (vs. subcutaneous injection)

The shorter duration means less risk of late-onset hypoglycemia, and the needle-free delivery is a major advantage for people with needle aversion. But it also means Afrezza may not provide enough coverage for high-fat or high-carb meals that cause extended blood sugar rises.

Alternative 1: Humalog (Insulin Lispro)

Humalog is one of the most widely prescribed rapid-acting injectable insulins. Made by Eli Lilly, it's been on the market since 1996 and is available at virtually every pharmacy in the country.

• Onset: 15-30 minutes
• Peak: 1-2 hours
• Duration: 3-5 hours
• Forms: Vials, KwikPens, cartridges
• Cost: Generic insulin lispro is available for around $25-$100 per vial. Brand Humalog retails for $250-$350 but Lilly offers a $35 cap for many patients.

Humalog's longer duration can be an advantage for meals that cause slow, sustained blood sugar rises. It's also available in generic form (insulin lispro), making it one of the most affordable rapid-acting options.

Alternative 2: NovoLog (Insulin Aspart)

NovoLog is another widely used rapid-acting insulin, made by Novo Nordisk. It has a very similar profile to Humalog and is interchangeable for most patients.

• Onset: 10-20 minutes
• Peak: 1-3 hours
• Duration: 3-5 hours
• Forms: Vials, FlexPens, PenFill cartridges
• Cost: Retail price around $250-$350 per vial for brand; authorized generic available. Novo Nordisk offers savings programs.

NovoLog is compatible with most insulin pumps and is commonly prescribed alongside basal insulin for both type 1 and type 2 diabetes.

Alternative 3: Apidra (Insulin Glulisine)

Apidra is a rapid-acting insulin made by Sanofi. It's less commonly prescribed than Humalog or NovoLog but works similarly.

• Onset: 15-30 minutes
• Peak: 1-2 hours
• Duration: 3-5 hours
• Forms: Vials, SoloStar pens
• Cost: Similar retail pricing to other brand rapid-acting insulins; generic versions may become available.

Apidra may be a good option if your insurance covers it on a preferred tier while other rapid-acting insulins are non-preferred.

Alternative 4: Lyumjev (Insulin Lispro-aabc)

Lyumjev is the closest injectable alternative to Afrezza in terms of speed. Made by Eli Lilly, it's an ultra rapid-acting insulin — faster than standard Humalog.

• Onset: ~5-10 minutes (faster than standard rapid-acting insulins)
• Peak: ~1-2 hours
• Duration: ~4-5 hours
• Forms: Vials, KwikPens
• Cost: Retail price around $250-$350; Lilly savings programs may apply.

If you liked Afrezza's speed but need an injectable option, Lyumjev is the next best thing. It uses added ingredients to help insulin absorb faster at the injection site.

What About Non-Insulin Alternatives?

If you have type 2 diabetes and were considering Afrezza to avoid adding injectable insulin to your regimen, talk to your doctor about these non-insulin options:

• GLP-1 receptor agonists (Ozempic, Trulicity, Mounjaro): These aren't insulin but help lower blood sugar, reduce appetite, and may help with weight management. Some are once-weekly injections.
• SGLT2 inhibitors (Jardiance, Farxiga): Oral medications that help your body remove excess glucose through urine.
• DPP-4 inhibitors (Januvia, Tradjenta): Oral medications that help regulate blood sugar after meals.

These won't replace mealtime insulin for type 1 diabetes, but for type 2 diabetes, they may reduce or eliminate the need for mealtime insulin altogether.

Final Thoughts

Afrezza is a unique medication, and there's nothing exactly like it on the market. But if you can't get it right now, you have solid alternatives — especially Lyumjev if speed is your priority, or generic insulin lispro if cost is the main concern.

Before switching, always talk to your doctor. They can help you find the right alternative based on your specific diabetes management plan, insurance coverage, and preferences.

Still hoping to get Afrezza? Check out our guides on how to find Afrezza in stock and how to save money on Afrezza — there may be options you haven't tried yet.